4
Changes in Ownership
Atea Pharmaceuticals, Inc. Filed Acc 0000899243-22-004182
Options or other derivatives
- President, CEO, and Chairman acquired 378,033 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Sommadossi Jean-Pierre President, CEO, and Chairman | 2022-01-31 | Grant or award · Stock Option (Right to Buy) | +378,033 | 378,033 | D | ||
Loading xslF345X03/doc4.xml…